Richard Pulik - Mar 29, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CFO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Stock symbol
ROIV
Transactions as of
Mar 29, 2023
Transactions value $
-$12,047
Form type
4
Date filed
3/31/2023, 09:30 PM
Previous filing
Mar 3, 2023
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Other -$12K -1.64K -0.73% $7.35 222K Mar 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.